Mursla Competitors and Similar CompaniesClear all

Mursla's competitors and similar companies include Precipio, MDxHealth, Inanovate and Chundsell Medicals.
Mursla
Mursla
Mursla is a cancer liquid biopsy company.
Precipio
Precipio
Precipio (formerly Transgenomic) is a company operating as a cancer diagnostics reference laboratory providing products and services to the oncology market.
MDxHealth
MDxHealth
MDxHealth is a molecular diagnostics company that develops and commercializes tests for cancer and other urologic diseases diagnosis.
Inanovate
Inanovate
Inanovate is a company developing technology for screening and analyzing proteins.
Chundsell Medicals
Chundsell Medicals
Chundsell Medicals is a company working with prostate cancer patients
Founding Date
Founding Date
2017
Founding Date
1997
Founding Date
2003
Founding Date
2007
Founding Date
2007
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Cambridge, GB HQ
Milton, GB
Locations
Omaha, US HQ
Glasgow, GB
New Haven, US
Omaha, US
Locations
Herstal, BE HQ
Nijmegen, NL
Irvine, US
Plano, US
Locations
Sioux Falls, US HQ
Raleigh, US
Locations
Solna, SE HQ
Solna, SE
Employees
Employees
16
Employees
4235% increase
Employees
252
Employees
19
Employees
109% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
9.3 m
Valuation ($)
93.5 m
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$24m (FY, 2025)
Revenue (est.)
$107.9m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$13.3m (FY, 2025)
Cost of goods
$36.1m (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$10.7m (FY, 2025)
Gross profit
$71.8m (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
N/A
Net income
($363k) (FY, 2025)
Net income
($33.5m) (FY, 2025)
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 2m (almost 9 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 3.1m (about 7 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 2m
Total funding raised
$ 1.5m
Total funding raised
$ 1.1m
Total funding raised
$ 3.6m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Precipio
HQ
Omaha, US
Employees
42↑ 35% increase

Precipio (formerly Transgenomic) is a company operating as a cancer diagnostics reference laboratory providing products and services to the oncology market.

View company
MDxHealth
HQ
Herstal, BE
Employees
252

MDxHealth is a molecular diagnostics company that develops and commercializes tests for cancer and other urologic diseases diagnosis.

View company
Inanovate
HQ
Sioux Falls, US
Employees
19

Inanovate is a company developing technology for screening and analyzing proteins.

View company
Chundsell Medicals
HQ
Solna, SE
Employees
10↓ 9% decrease

Chundsell Medicals is a company working with prostate cancer patients

View company